Fort Myers, FL, October 19, 2011 --(PR.com
)-- Dr. Constantine Mantz, chief medical officer of 21st Century Oncology, presented new research at the 53rd annual American Society of Radiation Oncology meeting in Miami, Florida, this month. Dr. Mantz’s research combines stereotactic body radiotherapy (SBRT) and the Calypso System in order to localize the treatment of prostate cancer. This localization, in turn, decreases the toxicity of radiation to other organs in the body and can minimize adverse side effects such as sexual dysfunction and incontinence.
SBRT differs from traditional radiotherapy for prostate cancer in that higher doses are given over a shorter number of treatments. Using SBRT along with the Calypso System, a device which enables physicians to deliver an increased dose of radiation directly to the tumor while helping to spare the surrounding organs, allows men to effectively combat prostate cancer and for many patients, it can serve as a viable alternative to invasive surgery.
According to Dr. Mantz, SBRT is showing promising results. “Results from this research study show that real-time tumor tracking with SBRT for early stage prostate cancer has clinically significant benefits in improving the quality of life after diagnosis and treatment,” said Dr. Mantz.
Dr. Mantz most recently presented research findings on the Calypso System to the American Urological Association and has also been published in Urology, the journal for the International Society of Urologists.
“Prostate cancer is, unfortunately, a very prevalent disease in our society. That is why continued research is so important,” Dr. Mantz says. “It’s an honor to present this research to a group of peers and to be able to inform the medical community about these advancements in treatment.”
About 21st Century Oncology
Headquartered in Fort Myers, 21st Century Oncology, Inc. is a leading developer and operator of radiation therapy centers in the U.S. For 30 years, 21st Century Oncology has been committed to providing premier, quality, cost-effective radiation therapy services that are responsive to the needs of its patients through continuous improvement and innovation. The company operates in 16 states and has more than 20 offices in Southwest Florida.